Jaguar Health Subsidiary Napo Pharmaceuticals Signs License Agreement with its Italian Subsidiary, Napo EU S.p.A., to Develop and Commercialize Crofelemer and Lechlemer in Europe
Stock Information for Jaguar Health Inc.
Loading
Please wait while we load your information from QuoteMedia.